Glucose attenuation of scopolamine- and age-induced deficits in spontaneous alternation behavior and regional brain [3H]2-deoxyglucose uptake in mice
Stone, W.S.; Rudd, R.J.; Gold, P.E.
Psychobiology (Austin, Tx) 20(4): 270-279
1992
ISSN/ISBN: 0889-6313
Accession: 075640537
PDF emailed within 1 workday: $29.90
Related References
Stone, W.S.; Rudd, R.J.; Gold, P.E. 1992: Glucose attenuation of scopolamine- and age-induced deficits in spontaneous alternation behavior and regional brain tritiated 2-deoxyglucose uptake in mice Psychobiology 20(4): 270-279Parsons, M.W.; Gold, P.E. 1992: Scopolamine-induced deficits in spontaneous alternation performance: attenuation with lateral ventricle injections of glucose Behavioral and Neural Biology 57(1): 90-92
Sarter, M.; Bodewitz, G.; Stephens, D.N. 1988: Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines Psychopharmacology 94(4): 491-495
Stone, W.S.; Walser, B.; Gold, S.D.; Gold, P.E. 1991: Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists Behavioral Neuroscience 105(2): 264-271
Lelong, Véronique.; Lhonneur, L.; Dauphin, Fçois.; Boulouard, M. 2003: BIMU 1 and RS 67333, two 5-HT4 receptor agonists, modulate spontaneous alternation deficits induced by scopolamine in the mouse Naunyn-Schmiedeberg's Archives of Pharmacology 367(6): 621-628
Means, L.W.; Holsten, R.D.; Long, M.; High, K.M. 1996: Scopolamine- and morphine-induced deficits in water maze alternation: failure to attenuate with glucose Neurobiology of Learning and Memory 66(2): 167-175
Means, L.W.; Edmonds, S.M. 1998: Glucose minimally attenuates scopolamine-but not morphine-induced deficits on a water maze alternation task Journal of Neural Transmission 105(10-12): 1171-1185
Jaffard, R..; Mocaer, E..; Poignant, J.-C..; Micheau, J..; Marighetto, A..; Meunier, M..; Béracochéa, D.. 1991: Effects of tianeptine on spontaneous alternation, simple and concurrent spatial discrimination learning and on alcohol-induced alternation deficits in mice Behavioural Pharmacology 2(1): 37-46
Ukai, M.; Shinkai, N.; Kameyama, T. 1996: Senktide attenuates scopolamine-induced impairment of spontaneous alternation performance in mice Neurobiology of Aging 17(4 Suppl): S67
Cervini, M.A.; Banfi, L.; Mcarthur, R.A. 1993: Scopolamine-induced memory impairments Effects on spontaneous alternation in young mice Journal of Psychopharmacology (ABSTR BOOK): A43
Ukai, M.; Shinkai, N.; Kameyama, T. 1996: Neurokinin A improves scopolamine-induced impairment of spontaneous alternation performance in mice Shibuya, T International Academy for Biomedical and Drug Research; Preclinical and clinical strategies for the treatment of neurodegenerative, cerebrovascular and mental disorders 232-236
Sarter, M.; Bodewitz, G.; Stephens, D.N. 1988: Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist β-carbolines Psychopharmacologia 94(4): 491-495
Kameyama, T.; Ukai, M.; Shinkai, N. 1998: Ameliorative effects of tachykinins on scopolamine-induced impairment of spontaneous alternation performance in mice Methods and Findings in Experimental and Clinical Pharmacology 20(7): 555-560
Ukai, M.; Shinkai, N.; Kameyama, T. 1996: Neurokinin a and senktide attenuate scopolamine-induced impairment of spontaneous alternation performance in mice Nihon Shinkei Seishin Yakurigaku Zasshi 16(3): 97-101
Itoh, J.; Ukai, M.; Kameyama, T. 1993: Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice European Journal of Pharmacology 236(3): 341-345